BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

Cytomegalovirus (CMV) has been recognized as one of the most important opportunistic
pathogens in transplant recipients. Direct clinical syndromes due to CMV are associated …

Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …

Despite remarkable improvements in its diagnosis, prevention, and treatment,
cytomegalovirus (CMV) remains the single most important pathogen after solid organ …

The introduction and combination of more-potent immunosuppressive regimens, and the
increased transplantation of organs into more severely ill patients, have again placed …

Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …

Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …

After allotransplantation, cytomegalovirus (CMV) may be transmitted from the donor organ,
giving rise to primary infection in a CMV negative recipient or reinfection in one who is CMV …